VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), a small-cap biotech company with a market capitalization of $2.21 million, has announced the selection of an intravitreal (IVT) formulation, ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

With pharmaceutical companies heavily investing in R&D and precision medicine, the demand for high-quality specialty APIs is ...

Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...

Sun Pharma's net profit jumped 15% to Rs 2,903 crore in Q3 FY25, driven by strong sales across geographies. Revenue rose to ...

The pharma major's consolidated net profit increased 15.04% to Rs 2,903.38 crore on 10.46% rise in revenue from operations to Rs 13,675.46 crore in Q3 FY25 over Q3 FY24.

Mumbai: Bajaj Healthcare Limited has announced that it has received approval from the Drug Controller General of India (DCGI) ...

Sequentially, revenue from operations grew by 2.9 per cent, whereas profit after tax (PAT) fell by 4.5 per cent ...

Sun Pharmaceutical Industries reported a 15 percent on-year increase in consolidated net profit, reaching Rs 2,903 crore for ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a ...

Sun Pharmaceutical Industries on Friday said its consolidated net profit increased 15 per cent on-year to Rs 2,903 crore in the December quarter, riding on robust sales across geographies. The drug ...